Phlexglobal Expands its Monitoring Services
22 April 2009-Phlexglobal, a leading specialist Clinical Research Organisation (CRO) delivering flexible support solutions for all aspects of the clinical study process, has responded to the increasing demand for flexible skilled monitoring resource by expanding its monitoring services division.
The Monitoring Services division is successfully supporting clinical research projects within both the commercial and non-commercial (NHS) sectors in the UK. With a team of highly skilled and experienced CRAs (clinical research associates) Phlexglobal is able to monitor projects on a short or long term basis across a wide range of therapeutic areas and offer clients a number of costing and project management options.
Sarah Tucker, Phlexglobal’s head of task force services, explained: “The industry needs skilled and experienced CRAs to ensure clinical studies are monitored appropriately to ensure regulatory compliance. We have seen that there is a shortage of suitably skilled CRAs and the current economic climate means companies are either unable or reluctant to take on trainees due to the costs involved in training them. Therefore, we expanded our task force team to be able to deliver high calibre, interim CRA resource whether on a short or long term basis.”
Sarah added: “We have built a “pool of excellence”, drawing from our extensive base of trained and experienced CRAs with both commercial and non-commercial backgrounds. It is very exciting to be able to take on a range of monitoring projects, either as a whole or in parts and be able to provide our clients with an invaluable resource in this highly pressurised financial climate.”
Phlexglobal specialises in flexible staff provisioning, eTMFs, scanning, clinical trial management and support, archiving and training. With a strong reputation for providing high quality professional study support services, Phlexglobal counts 16 of the top 20 pharmaceutical companies across the globe as clients and is based in Amersham, Buckinghamshire.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
